Neurocrine Biosciences Aktie
132,30
EUR
+2,90
EUR
+2,24
%
155,52
USD
+1,27
USD
+0,82
%
Werbung
Neurocrine Biosciences Aktie Analyse
| 14.12.07 | Neurocrine Biosciences underperform | Bear Stearns Companies Inc. | |
| 14.12.07 | Neurocrine Biosciences sell | Piper Jaffray & Co. | |
| 14.12.07 | Neurocrine Biosciences underperform | Jefferies & Company Inc. | |
| 29.06.06 | Neurocrine Biosciences reduce | UBS | |
| 23.06.06 | Neurocrine Biosciences underweight | Morgan Stanley | |
| 23.06.06 | Neurocrine Biosciences sell | Citigroup | |
| 16.06.06 | Neurocrine Biosciences underperform | Leerink Swann | |
| 16.06.06 | Neurocrine Biosciences underperform | Robert W. Baird | |
|
Werbung
|
|||
| 16.06.06 | Neurocrine Biosciences Underperform | Leerink Swann | |
| 18.05.06 | Neurocrine Biosciences underperform | Jefferies & Co | |
Werbung
Werbung